January 22, 2024
Takeshi Iwatsubo, Director, Japan Society for Dementia Research Pharma companies are vying to develop the next Alzheimer’s disease (AD) treatments that would follow Eisai’s Leqembi (lecanemab). Eli Lilly has a similar drug under regulatory review, while Roche is pursuing a...read more